NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
Will Freeman results 7 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Will Freeman ×Clear All Filters
Search Results
Conservation Biology · 2025 · Vol. 39 · Issue 2 · Wiley
Although the importance of social science to conservation practice and policy is well accepted, social scientists remain in the minority in conservation nongovernmental organizations (NGOs). We explored how social science has started to inform the work of WWT, an NGO dedicated to the restoration of wetlands for people and nature. Through reflections on our experiences working in WWT's social dimensions unit and interviews with...
Psychopharmacology · 2024 · Vol. 241 · Issue 6 · Springer
Rationale Attentional bias to drug-related stimuli is hypothesised to contribute towards addiction. However, the acute effects of Δ9-tetrahydrocannabinol (THC) on attentional bias to cannabis cues, the differential response in adults and adolescents, and the moderating effect of cannabidiol (CBD) are unknown. Objectives Our study investigated (1) the acute effects of vaporised cannabis on attentional bias to cannabis-related i...
The Cerebellum · 2022 · Vol. 23 · Issue 1 · Springer
Multiple system atrophy (MSA) is a fatal neurodegenerative disease of unknown etiology characterized by widespread aggregation of the protein alpha-synuclein in neurons and glia. Its orphan status, biological relationship to Parkinson’s disease (PD), and rapid progression have sparked interest in drug development. One significant obstacle to therapeutics is disease heterogeneity. Here, we share our process of developing a clin...